Harte Hanks (HHS) Cost of Revenue (2019 - 2026)

Harte Hanks (HHS) has 8 years of Cost of Revenue data on file, last reported at $11.3 million in Q1 2026.

• On a quarterly basis, Cost of Revenue fell 19.34% year-over-year to $11.3 million in Q1 2026; TTM through Mar 2026 was $47.2 million, a 17.16% decrease from a year earlier, with the FY2025 full-year figure at $49.9 million, down 11.91% from the prior year.
• Cost of Revenue for Q1 2026 stood at $11.3 million, down from $11.7 million in the prior quarter.
• Over the last five years, Cost of Revenue for HHS reached as high as $19.5 million in Q4 2022 and fell as low as $11.3 million in Q1 2026.
• Historically, Cost of Revenue has averaged $14.1 million across 5 years, with a median of $13.8 million in 2024.
• Across the five-year window, Cost of Revenue soared 154.44% in 2022 and fell 20.8% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $19.5 million in 2022, then retreated by 15.98% to $16.4 million in 2023, then fell by 9.85% to $14.8 million in 2024, then dropped by 20.8% to $11.7 million in 2025, then fell by 3.23% to $11.3 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $11.3 million in Q1 2026, $11.7 million in Q4 2025, and $11.7 million in Q3 2025.